These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quantitative investigation on the urinary excretion and metabolism of 3,4-dimethoxyphenylethylamine in schizophrenics and normal individuals. Hempel K; Ullrich H; Philippu G Biol Psychiatry; 1982 Jan; 17(1):49-59. PubMed ID: 7059639 [TBL] [Abstract][Full Text] [Related]
7. 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia. Narasimhachari N Biol Psychiatry; 1979 Feb; 14(1):215-9. PubMed ID: 420902 [No Abstract] [Full Text] [Related]
8. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics]. Zimmermann K; Moschke P; Wieder KH Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948 [TBL] [Abstract][Full Text] [Related]
9. 3,4-Dimethoxyphenylethylamine excretion of normals and schizophrenics, behaviour during total fasting. Knoll E; Wisser H; Emrich HM Clin Chim Acta; 1978 Nov; 89(3):493-502. PubMed ID: 709888 [TBL] [Abstract][Full Text] [Related]
10. Investigations on urinary excretion of 3,4 dimethoxyphenylethylamine (the pink spot), the Mauve factor and aromatic compounds in patients with schizophrenia. Rao BS; Narayanan HS; Reddy GN Indian J Med Res; 1971 Mar; 59(3):455-60. PubMed ID: 5090025 [No Abstract] [Full Text] [Related]
11. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders]. Matsumoto H; Pietruszewska I Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869 [No Abstract] [Full Text] [Related]
12. [Current status of studies on dimethoxyphenylethylamine in schizophrenia]. Friedhoff AJ Vestn Akad Med Nauk SSSR; 1969; 24(4):37-41. PubMed ID: 5346213 [No Abstract] [Full Text] [Related]
13. Time study of the urinary excretion of 3,4-dimethoxyphenylethylamine and 3,4-dimethoxyphenylacetic acid by schizophrenic and normal individuals. Vogel WH; Ahlberg CD; Horwitt MK Int J Neuropsychiatry; 1967 Jun; 3(3):292-7. PubMed ID: 6034737 [No Abstract] [Full Text] [Related]
14. [Contibution to the significance of 3,4-dimethoxyphenylethylamine in schizophrenias]. Hanzlícek L Cesk Psychiatr; 1967 Oct; 63(5):293-6. PubMed ID: 6065348 [No Abstract] [Full Text] [Related]
15. [Significance and identification of 3,4-dimethoxyphenylethylamine in the urine of schizophrenic patients (pink spot reaction)]. Stanciu E; Csiky K; Rácz E Neurol Psihiatr Neurochir; 1971; 16(4):305-12. PubMed ID: 5118389 [No Abstract] [Full Text] [Related]
16. 3,4-dimethoxyphenylethylamine in schizophrenia. Williams CH; Gibson JG; McCormick WO Nature; 1966 Sep; 211(5054):1195. PubMed ID: 6008085 [No Abstract] [Full Text] [Related]
17. [Radioimmunological determination of 3,4-dimethoxyphenylethylamine in urine (author's transl)]. Knoll E; Wisser H Clin Chim Acta; 1976 May; 68(3):327-32. PubMed ID: 1277548 [No Abstract] [Full Text] [Related]
18. The "pink spot," 3,4-dimethoxyphenylethylamine, common tea, and schizophrenia. Stabenau JR; Creveling CR; Daly J Am J Psychiatry; 1970 Nov; 127(5):611-6. PubMed ID: 5491537 [No Abstract] [Full Text] [Related]
19. Does 3,4-dimethoxyphenylethylamine occur in the urine from schizophrenics and normal persons? Pind K; Faurbye A Acta Psychiatr Scand; 1966; 42(3):246-51. PubMed ID: 5959088 [No Abstract] [Full Text] [Related]
20. A new concept and further support for the importance and occurrence of 3,4-dimethoxyphenylethylamine (DMPEA) in urine of schizophrenic patients. Kalbhen DA; Braun G Pharmacology; 1973; 9(1):52-6. PubMed ID: 4708978 [No Abstract] [Full Text] [Related] [Next] [New Search]